Outcome of High Resolution Computed Tomography (HRCT) Scan of Chest of COVID-19 Affected Patients: A Study in a COVID-19 Dedicated Hospital

Marzuk Ahamed; Mohammad Ripon Sikder; Mohammad Mojibur Rahman; Sohel Rana Sumon; Mohammad Motiur Rahman; Abdur Rab Akanda; Mohammad Salehin Abedin

doi:doi:10.11648/j.ijmi.20241202.15

Research Article |

Outcome of High Resolution Computed Tomography (HRCT) Scan of Chest of COVID-19 Affected Patients: A Study in a COVID-19 Dedicated Hospital

Marzuk Ahamed^*, Mohammad Ripon Sikder, Mohammad Mojibur Rahman, Sohel Rana Sumon, Mohammad Motiur Rahman, Abdur Rab Akanda, Mohammad Salehin Abedin

Published in International Journal of Medical Imaging (Volume 12, Issue 2)

Received: 1 November 2023 Accepted: 2 January 2024 Published: 24 May 2024

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Introduction: Recent studies have assessed the importance of chest CT scans, particularly high-resolution CT (HRCT), in hospitalized COVID-19 patients who are suspected of having the virus or have had false negative test results. Objective: The aim of this study was to determine the outcome of High-Resolution Computed Tomography (HRCT) of chest of confirmed COVID-19 positive cases. Methodology: This was a cross-sectional prospective study carried out in the department of Radiology and imaging in collaboration with the department of Virology and COVID unit in IbnSina Hospital, Dhaka, Bangladesh during January, 2022 to June, 2022. A total of 300 confirmed COVID-19 positive admitted cases in the hospital, aged above 18 years were enrolled in this study. All the patients were under went High Resolution Computed Tomography (HRCT) of Chest scan. The collected data were cleaned, edited and entered into computer for analysis. The data were analyzed by SPSS-23.0. The ethical clearance of this study was obtained from the Ethics Committee of School of Public Health & Life Science, University of South Asia, and Dhaka, Bangladesh. Results: In this study a total of 300 COVID-19 positive cases were enrolled. Among the patients, the majority203 (67.66%) patients belonged to the age group >52 years, which was the highest and followed by 44 (14.66%) age group (43-52) years, 36 (12%) (33-42) years, 14 (4.66%) (22-32) years and 3 (1%) <22 years. According to sex distribution, the majority cases 160 (53.33%) were male and 140 (46.66%) were female. According to the distribution of clinical presentation, the highest symptom was observed, general weakness 300 (100%) and followed by sneezing 288 (96%), fever 246 (82%), headache 239 (79.66%), cough 232 (77.33%), respiratory distress, 225 (75%), cough and SOB, 220 (73.33%), loss of smell, 222 (74%), lac of apatite, 216 (72%), asthma 130 (43.33) and pneumonia, 120 (40%). According to the distribution of HRCT findings of chest of the COVID-19 positive cases, 163 (54.33%) had Ground glass opacity, which was the largest observation and followed by 66 (22%), Ground glass opacity with pneumonia, 34 (11.33%) Ground glass opacity with consolidation, 31 (10.33) Ground glass opacity with fibrosis, and 6 (2%) Ground glass opacity with pleural effusion. Conclusion: The results of this study indicate that doing a high-resolution computed tomography (HRCT) scan of the chest is a valuable method for diagnosing and assessing the response to treatment in COVID-19 patients. Additionally, it serves as a significant predictor for future prognosis.

Published in	International Journal of Medical Imaging (Volume 12, Issue 2)
DOI	10.11648/j.ijmi.20241202.15
Page(s)	51-56
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Outcome. HRCT, Scan, Chest COVID-19, Positive, Cases, Ground Glass Opacity (GGO), Dedicated, Hospital

References

[1]	Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. New Engl J Med 2020; 382: 727-33. [PMC free article] [PubMed] [Google Scholar]
[2]	Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. Lancet 2020; 395: 470-3. [PMC free article] [PubMed] [Google Scholar]
[3]	Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J Med Virol 2020; 92: 401-2. [PMC free article] [PubMed] [Google Scholar]
[4]	Sohrabi C, Alsafi Z, O’Neill N, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Inter J Surg 2020; 76: 71-6. [Google Scholar]
[5]	Kozera B, Rapacz M. Reference genes in real-time PCR. J Appl Genet. 2013 Nov; 54(4): 391-406. PMID: 24078518; PMCID: PMC3825189. https://doi.org/10.1007/s13353-013-0173-x
[6]	Ishfaq A, Farooq SM, Goraya A, Yousaf M, Gilani SA, Kiran A, Ayoub M, Javed A, Bacha R. Role of High Resolution Computed Tomography chest in the diagnosis and evaluation of COVID-19 patients-A systematic review and meta-analysis. European journal of radiology open. 2021 Jan 1; 8: 100350.
[7]	Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing for Coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology 2020; 296: E32-40.
[8]	Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity of chest CT for COVID-19: Comparison to RT-PCR. Radiology 2020; 296: E115-7.
[9]	Huang P, Liu T, Huang L, Liu H, Lei M, Xu W, et al. Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion. Radiology 2020; 295: 22-3.
[10]	Chen D, Jiang X, Hong Y, Wen Z, Wei S, Peng G, et al. Can chest CT features distinguish patients with negative from those with positive initial RT-PCR results for coronavirus disease (COVID-19)? AJR Am J Roentgenol 2020; 216: 66-70.
[11]	Raman S, Bahar T. COVID 19: The New Threat, Int J Infect. 2020; 7(1): e102184. https://doi.org/10.5812/iji102184
[12]	Bayraktaroğlu S, Çinkooğlu A, Ceylan N, Savaş R (2020) The novel coronavirus pneumonia (COVID-19): a pictorial review of chest CT features. DiagnIntervRadiol.
[13]	Kim H, Hong H, Yoon SH. Diagnostic performance of CT and reverse transcriptase polymerase chain reaction for coronavirus disease 2019: A meta- analysis. Radiology 2020; 296: E145-55.
[14]	Zhang, N., Xu, X., Zhou, L. et al. Clinical characteristics and Chest CT imaging features of critically ill COVID 19 patients. EurRadiol (2020).
[15]	Adams HJ, Kwee TC, Yakar D, Hope MD, Kwee RM. Systematic review and meta-analysis on the value of chest CT in the diagnosis of coronavirus disease (COVID-19): Sol Scientiae, Illustra Nos. AJR Am J Roentgenol 2020; 215: 1342-50.
[16]	Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, Diao K, Lin B, Zhu X, Li K, Li S, Shan H, Jacobi A, Chung M. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology. 2020 Jun; 295(3): 200463. https://doi.org/10.1148/radiol.2020200463
[17]	Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH, Chung M, et al. Radiological society of North America expert consensus document on reporting chest CT findings related to COVID-19: Endorsed by the society of thoracic radiology, the American College of Radiology, and RSNA. J Thorac Imaging 2020; 35: 219-27.
[18]	Paul NS, Roberts H, Butany J, Chung T, Gold W, Mehta S, Konen E, Rao A, Provost Y, Hong HH, Zelovitsky L, Weisbrod GL. Radiologic pattern of disease in patients with severe acute respiratory syndrome: the Toronto experience. Radiographics 2004; 24: 553-63. [Crossref] [PubMed]
[19]	Inui S, Fujikawa A, Jitsu M, Kunishima N, Watanabe S, Suzuki Y, Umeda S, Uwabe Y. Chest CT Findings in Cases from the Cruise Ship “Diamond Princess” with Coronavirus Disease 2019 (COVID-Radiology: Cardiothorac Imaging 2020. https://doi.org/10.1148/ryct.2020200110
[20]	Xu R, Du M, Li L, Zhen Z, Wang H, Hu X. CT imaging of one extended family cluster of corona virus disease 2019 (COVID-19) including adolescent patients and “silent infection”. Quant Imaging Med Surg 2020; 10: 800-804. [Crossref] [PubMed]
[21]	Zhou Z, Guo D, Li C, Fang Z, Chen L, Yang R, Li X, Zeng W. Coronavirus disease 2019: initial chest CT findings. Eur Radiol 2020. Epub ahead of print. [Crossref] [PubMed]
[22]	Bai HX, Hsieh B, Xiong Z, Halsey K, Choi JW, Tran TML, Pan I, Shi LB, Wang DC, Mei J, Jiang XL, Zeng QH, Egglin TK, Hu PF, Agarwal S, Xie F, Li S, Healey T, Atalay MK, Liao WH. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology 2020. Epub ahead of print. [Crossref] [PubMed]
[23]	Li Y, Xia L. Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management. AJR Am J Roentgenol 2020. Epub ahead of print. [Crossref] [PubMed]
[24]	Ng MY, Lee M, Yang J, Yang F, Li X, Wang H, Lui M, Lo C, Leung B, Khong P, Hui C, Yuen K, Kuo M. Imaging profile of the COVID-19 infection: Radiologic findings and literature review. Radiology Cardiothorac Imaging 2020.

Cite This Article

Plain Text BibTeX RIS

APA Style

Ahamed, M., Sikder, M. R., Rahman, M. M., Sumon, S. R., Rahman, M. M., et al. (2024). Outcome of High Resolution Computed Tomography (HRCT) Scan of Chest of COVID-19 Affected Patients: A Study in a COVID-19 Dedicated Hospital. International Journal of Medical Imaging, 12(2), 51-56. https://doi.org/10.11648/j.ijmi.20241202.15

Copy | Download

ACS Style

Ahamed, M.; Sikder, M. R.; Rahman, M. M.; Sumon, S. R.; Rahman, M. M., et al. Outcome of High Resolution Computed Tomography (HRCT) Scan of Chest of COVID-19 Affected Patients: A Study in a COVID-19 Dedicated Hospital. Int. J. Med. Imaging 2024, 12(2), 51-56. doi: 10.11648/j.ijmi.20241202.15

Copy | Download

AMA Style

Ahamed M, Sikder MR, Rahman MM, Sumon SR, Rahman MM, et al. Outcome of High Resolution Computed Tomography (HRCT) Scan of Chest of COVID-19 Affected Patients: A Study in a COVID-19 Dedicated Hospital. Int J Med Imaging. 2024;12(2):51-56. doi: 10.11648/j.ijmi.20241202.15

Copy | Download

@article{10.11648/j.ijmi.20241202.15,
  author = {Marzuk Ahamed and Mohammad Ripon Sikder and Mohammad Mojibur Rahman and Sohel Rana Sumon and Mohammad Motiur Rahman and Abdur Rab Akanda and Mohammad Salehin Abedin},
  title = {Outcome of High Resolution Computed Tomography (HRCT) Scan of Chest of COVID-19 Affected Patients: A Study in a COVID-19 Dedicated Hospital
},
  journal = {International Journal of Medical Imaging},
  volume = {12},
  number = {2},
  pages = {51-56},
  doi = {10.11648/j.ijmi.20241202.15},
  url = {https://doi.org/10.11648/j.ijmi.20241202.15},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmi.20241202.15},
  abstract = {Introduction: Recent studies have assessed the importance of chest CT scans, particularly high-resolution CT (HRCT), in hospitalized COVID-19 patients who are suspected of having the virus or have had false negative test results. Objective: The aim of this study was to determine the outcome of High-Resolution Computed Tomography (HRCT) of chest of confirmed COVID-19 positive cases. Methodology: This was a cross-sectional prospective study carried out in the department of Radiology and imaging in collaboration with the department of Virology and COVID unit in IbnSina Hospital, Dhaka, Bangladesh during January, 2022 to June, 2022. A total of 300 confirmed COVID-19 positive admitted cases in the hospital, aged above 18 years were enrolled in this study. All the patients were under went High Resolution Computed Tomography (HRCT) of Chest scan. The collected data were cleaned, edited and entered into computer for analysis. The data were analyzed by SPSS-23.0. The ethical clearance of this study was obtained from the Ethics Committee of School of Public Health & Life Science, University of South Asia, and Dhaka, Bangladesh. Results: In this study a total of 300 COVID-19 positive cases were enrolled. Among the patients, the majority203 (67.66%) patients belonged to the age group >52 years, which was the highest and followed by 44 (14.66%) age group (43-52) years, 36 (12%) (33-42) years, 14 (4.66%) (22-32) years and 3 (1%) <22 years. According to sex distribution, the majority cases 160 (53.33%) were male and 140 (46.66%) were female. According to the distribution of clinical presentation, the highest symptom was observed, general weakness 300 (100%) and followed by sneezing 288 (96%), fever 246 (82%), headache 239 (79.66%), cough 232 (77.33%), respiratory distress, 225 (75%), cough and SOB, 220 (73.33%), loss of smell, 222 (74%), lac of apatite, 216 (72%), asthma 130 (43.33) and pneumonia, 120 (40%). According to the distribution of HRCT findings of chest of the COVID-19 positive cases, 163 (54.33%) had Ground glass opacity, which was the largest observation and followed by 66 (22%), Ground glass opacity with pneumonia, 34 (11.33%) Ground glass opacity with consolidation, 31 (10.33) Ground glass opacity with fibrosis, and 6 (2%) Ground glass opacity with pleural effusion. Conclusion: The results of this study indicate that doing a high-resolution computed tomography (HRCT) scan of the chest is a valuable method for diagnosing and assessing the response to treatment in COVID-19 patients. Additionally, it serves as a significant predictor for future prognosis.
},
 year = {2024}
}

Copy | Download

TY  - JOUR
T1  - Outcome of High Resolution Computed Tomography (HRCT) Scan of Chest of COVID-19 Affected Patients: A Study in a COVID-19 Dedicated Hospital

AU  - Marzuk Ahamed
AU  - Mohammad Ripon Sikder
AU  - Mohammad Mojibur Rahman
AU  - Sohel Rana Sumon
AU  - Mohammad Motiur Rahman
AU  - Abdur Rab Akanda
AU  - Mohammad Salehin Abedin
Y1  - 2024/05/24
PY  - 2024
N1  - https://doi.org/10.11648/j.ijmi.20241202.15
DO  - 10.11648/j.ijmi.20241202.15
T2  - International Journal of Medical Imaging
JF  - International Journal of Medical Imaging
JO  - International Journal of Medical Imaging
SP  - 51
EP  - 56
PB  - Science Publishing Group
SN  - 2330-832X
UR  - https://doi.org/10.11648/j.ijmi.20241202.15
AB  - Introduction: Recent studies have assessed the importance of chest CT scans, particularly high-resolution CT (HRCT), in hospitalized COVID-19 patients who are suspected of having the virus or have had false negative test results. Objective: The aim of this study was to determine the outcome of High-Resolution Computed Tomography (HRCT) of chest of confirmed COVID-19 positive cases. Methodology: This was a cross-sectional prospective study carried out in the department of Radiology and imaging in collaboration with the department of Virology and COVID unit in IbnSina Hospital, Dhaka, Bangladesh during January, 2022 to June, 2022. A total of 300 confirmed COVID-19 positive admitted cases in the hospital, aged above 18 years were enrolled in this study. All the patients were under went High Resolution Computed Tomography (HRCT) of Chest scan. The collected data were cleaned, edited and entered into computer for analysis. The data were analyzed by SPSS-23.0. The ethical clearance of this study was obtained from the Ethics Committee of School of Public Health & Life Science, University of South Asia, and Dhaka, Bangladesh. Results: In this study a total of 300 COVID-19 positive cases were enrolled. Among the patients, the majority203 (67.66%) patients belonged to the age group >52 years, which was the highest and followed by 44 (14.66%) age group (43-52) years, 36 (12%) (33-42) years, 14 (4.66%) (22-32) years and 3 (1%) <22 years. According to sex distribution, the majority cases 160 (53.33%) were male and 140 (46.66%) were female. According to the distribution of clinical presentation, the highest symptom was observed, general weakness 300 (100%) and followed by sneezing 288 (96%), fever 246 (82%), headache 239 (79.66%), cough 232 (77.33%), respiratory distress, 225 (75%), cough and SOB, 220 (73.33%), loss of smell, 222 (74%), lac of apatite, 216 (72%), asthma 130 (43.33) and pneumonia, 120 (40%). According to the distribution of HRCT findings of chest of the COVID-19 positive cases, 163 (54.33%) had Ground glass opacity, which was the largest observation and followed by 66 (22%), Ground glass opacity with pneumonia, 34 (11.33%) Ground glass opacity with consolidation, 31 (10.33) Ground glass opacity with fibrosis, and 6 (2%) Ground glass opacity with pleural effusion. Conclusion: The results of this study indicate that doing a high-resolution computed tomography (HRCT) scan of the chest is a valuable method for diagnosing and assessing the response to treatment in COVID-19 patients. Additionally, it serves as a significant predictor for future prognosis.

VL  - 12
IS  - 2
ER  -

Copy | Download

Author Information

Marzuk Ahamed

Department of Public Health and Life Science, University of South Asia, Dhaka, Bangladesh

Contact Email
Mohammad Ripon Sikder

Department of Public Health and Life Science, University of South Asia, Dhaka, Bangladesh
Mohammad Mojibur Rahman

Department of Public Health and Life Science, University of South Asia, Dhaka, Bangladesh
Sohel Rana Sumon

Department of Public Health and Life Science, University of South Asia, Dhaka, Bangladesh
Mohammad Motiur Rahman

Department of Public Health and Life Science, University of South Asia, Dhaka, Bangladesh
Abdur Rab Akanda

Department of Public Health and Life Science, University of South Asia, Dhaka, Bangladesh
Mohammad Salehin Abedin

Department of Public Health and Life Science, University of South Asia, Dhaka, Bangladesh

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Ahamed, M., Sikder, M. R., Rahman, M. M., Sumon, S. R., Rahman, M. M., et al. (2024). Outcome of High Resolution Computed Tomography (HRCT) Scan of Chest of COVID-19 Affected Patients: A Study in a COVID-19 Dedicated Hospital. International Journal of Medical Imaging, 12(2), 51-56. https://doi.org/10.11648/j.ijmi.20241202.15

Copy | Download

ACS Style

Ahamed, M.; Sikder, M. R.; Rahman, M. M.; Sumon, S. R.; Rahman, M. M., et al. Outcome of High Resolution Computed Tomography (HRCT) Scan of Chest of COVID-19 Affected Patients: A Study in a COVID-19 Dedicated Hospital. Int. J. Med. Imaging 2024, 12(2), 51-56. doi: 10.11648/j.ijmi.20241202.15

Copy | Download

AMA Style

Ahamed M, Sikder MR, Rahman MM, Sumon SR, Rahman MM, et al. Outcome of High Resolution Computed Tomography (HRCT) Scan of Chest of COVID-19 Affected Patients: A Study in a COVID-19 Dedicated Hospital. Int J Med Imaging. 2024;12(2):51-56. doi: 10.11648/j.ijmi.20241202.15

Copy | Download

@article{10.11648/j.ijmi.20241202.15,
  author = {Marzuk Ahamed and Mohammad Ripon Sikder and Mohammad Mojibur Rahman and Sohel Rana Sumon and Mohammad Motiur Rahman and Abdur Rab Akanda and Mohammad Salehin Abedin},
  title = {Outcome of High Resolution Computed Tomography (HRCT) Scan of Chest of COVID-19 Affected Patients: A Study in a COVID-19 Dedicated Hospital
},
  journal = {International Journal of Medical Imaging},
  volume = {12},
  number = {2},
  pages = {51-56},
  doi = {10.11648/j.ijmi.20241202.15},
  url = {https://doi.org/10.11648/j.ijmi.20241202.15},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmi.20241202.15},
  abstract = {Introduction: Recent studies have assessed the importance of chest CT scans, particularly high-resolution CT (HRCT), in hospitalized COVID-19 patients who are suspected of having the virus or have had false negative test results. Objective: The aim of this study was to determine the outcome of High-Resolution Computed Tomography (HRCT) of chest of confirmed COVID-19 positive cases. Methodology: This was a cross-sectional prospective study carried out in the department of Radiology and imaging in collaboration with the department of Virology and COVID unit in IbnSina Hospital, Dhaka, Bangladesh during January, 2022 to June, 2022. A total of 300 confirmed COVID-19 positive admitted cases in the hospital, aged above 18 years were enrolled in this study. All the patients were under went High Resolution Computed Tomography (HRCT) of Chest scan. The collected data were cleaned, edited and entered into computer for analysis. The data were analyzed by SPSS-23.0. The ethical clearance of this study was obtained from the Ethics Committee of School of Public Health & Life Science, University of South Asia, and Dhaka, Bangladesh. Results: In this study a total of 300 COVID-19 positive cases were enrolled. Among the patients, the majority203 (67.66%) patients belonged to the age group >52 years, which was the highest and followed by 44 (14.66%) age group (43-52) years, 36 (12%) (33-42) years, 14 (4.66%) (22-32) years and 3 (1%) <22 years. According to sex distribution, the majority cases 160 (53.33%) were male and 140 (46.66%) were female. According to the distribution of clinical presentation, the highest symptom was observed, general weakness 300 (100%) and followed by sneezing 288 (96%), fever 246 (82%), headache 239 (79.66%), cough 232 (77.33%), respiratory distress, 225 (75%), cough and SOB, 220 (73.33%), loss of smell, 222 (74%), lac of apatite, 216 (72%), asthma 130 (43.33) and pneumonia, 120 (40%). According to the distribution of HRCT findings of chest of the COVID-19 positive cases, 163 (54.33%) had Ground glass opacity, which was the largest observation and followed by 66 (22%), Ground glass opacity with pneumonia, 34 (11.33%) Ground glass opacity with consolidation, 31 (10.33) Ground glass opacity with fibrosis, and 6 (2%) Ground glass opacity with pleural effusion. Conclusion: The results of this study indicate that doing a high-resolution computed tomography (HRCT) scan of the chest is a valuable method for diagnosing and assessing the response to treatment in COVID-19 patients. Additionally, it serves as a significant predictor for future prognosis.
},
 year = {2024}
}

Copy | Download

TY  - JOUR
T1  - Outcome of High Resolution Computed Tomography (HRCT) Scan of Chest of COVID-19 Affected Patients: A Study in a COVID-19 Dedicated Hospital

AU  - Marzuk Ahamed
AU  - Mohammad Ripon Sikder
AU  - Mohammad Mojibur Rahman
AU  - Sohel Rana Sumon
AU  - Mohammad Motiur Rahman
AU  - Abdur Rab Akanda
AU  - Mohammad Salehin Abedin
Y1  - 2024/05/24
PY  - 2024
N1  - https://doi.org/10.11648/j.ijmi.20241202.15
DO  - 10.11648/j.ijmi.20241202.15
T2  - International Journal of Medical Imaging
JF  - International Journal of Medical Imaging
JO  - International Journal of Medical Imaging
SP  - 51
EP  - 56
PB  - Science Publishing Group
SN  - 2330-832X
UR  - https://doi.org/10.11648/j.ijmi.20241202.15
AB  - Introduction: Recent studies have assessed the importance of chest CT scans, particularly high-resolution CT (HRCT), in hospitalized COVID-19 patients who are suspected of having the virus or have had false negative test results. Objective: The aim of this study was to determine the outcome of High-Resolution Computed Tomography (HRCT) of chest of confirmed COVID-19 positive cases. Methodology: This was a cross-sectional prospective study carried out in the department of Radiology and imaging in collaboration with the department of Virology and COVID unit in IbnSina Hospital, Dhaka, Bangladesh during January, 2022 to June, 2022. A total of 300 confirmed COVID-19 positive admitted cases in the hospital, aged above 18 years were enrolled in this study. All the patients were under went High Resolution Computed Tomography (HRCT) of Chest scan. The collected data were cleaned, edited and entered into computer for analysis. The data were analyzed by SPSS-23.0. The ethical clearance of this study was obtained from the Ethics Committee of School of Public Health & Life Science, University of South Asia, and Dhaka, Bangladesh. Results: In this study a total of 300 COVID-19 positive cases were enrolled. Among the patients, the majority203 (67.66%) patients belonged to the age group >52 years, which was the highest and followed by 44 (14.66%) age group (43-52) years, 36 (12%) (33-42) years, 14 (4.66%) (22-32) years and 3 (1%) <22 years. According to sex distribution, the majority cases 160 (53.33%) were male and 140 (46.66%) were female. According to the distribution of clinical presentation, the highest symptom was observed, general weakness 300 (100%) and followed by sneezing 288 (96%), fever 246 (82%), headache 239 (79.66%), cough 232 (77.33%), respiratory distress, 225 (75%), cough and SOB, 220 (73.33%), loss of smell, 222 (74%), lac of apatite, 216 (72%), asthma 130 (43.33) and pneumonia, 120 (40%). According to the distribution of HRCT findings of chest of the COVID-19 positive cases, 163 (54.33%) had Ground glass opacity, which was the largest observation and followed by 66 (22%), Ground glass opacity with pneumonia, 34 (11.33%) Ground glass opacity with consolidation, 31 (10.33) Ground glass opacity with fibrosis, and 6 (2%) Ground glass opacity with pleural effusion. Conclusion: The results of this study indicate that doing a high-resolution computed tomography (HRCT) scan of the chest is a valuable method for diagnosing and assessing the response to treatment in COVID-19 patients. Additionally, it serves as a significant predictor for future prognosis.

VL  - 12
IS  - 2
ER  -

Copy | Download